Early screening for hydronephrosis via urinalysis and PSA testing could serve as a low-cost, preventative diagnostic approach to identify urinary obstructions and improve the management and prognosis of underlying prostate diseases.
Over the years, I have encountered many people who have expressed a need for relief from their recurrent pain and discomfort but have been unable to find a concrete solution. These individuals have been the focus of my attention for quite some time. By nature, and experience, I am a problem solver and a solution planner. Through my ongoing research and observations, I have noticed that a common underlying cause of their issues is often related to symptoms of hydronephrosis.
What is hydronephrosis? It is a condition characterized by the swelling of a kidney due to a blockage in the urinary tract, which can result from various factors such as infection, pregnancy, prostate issues, or dietary restrictions. Until recently, this condition was often overlooked as a common occurrence that would resolve on its own without requiring further intervention. While I generally agree with this approach, in the evolving healthcare landscape, early detection of hydronephrosis can serve as a valuable preventative measure against underlying diseases. Early diagnosis may help prevent progression to more advanced stages. Specifically, regarding prostate disease and cancer, in addition to routine PSA screening, assessing the presence and severity of hydronephrosis should also be considered.
How should we screen for hydronephrosis? A urinalysis, including a Gram stain test, can help detect infections that may contribute to hydronephrosis. Additionally, assessing hormone levels in the urine is not typically used for diagnosing hydronephrosis. Instead, combining urinalysis results with a prostate-specific antigen (PSA) test can aid in evaluating prostate health and potential damage.
Are these tests currently being conducted, and if so, how are they being implemented in disease prevention?
Blood tests measuring PSA levels are currently used and have proven to be effective to some extent. However, routine follow-up and medication management as the primary approach to ongoing treatment have not yielded positive results. Prostate disease incidence and cancer-related deaths have actually increased, and medications used to manage this condition have not been effective. With the use of hydronephrosis screening, a different approach could be considered regarding which medications should be prescribed to treat and manage this specific cancer.
Something as simple as a urinalysis should not be overlooked as a means of prognosis. It is a low-cost option that holds significant and valuable meaning: a life saved.
As a graduate of the Clinical Sciences program at the University of Texas Health Sciences Center in San Antonio, I work on research grants for the university and have observed that the Center’s Continuing Research and Scientific Assemblies have been valuable in healthcare and ongoing medical advancements. Further investigation is underway in this area.
No Comment! Be the first one.